Introduction
The measurement of glycosylated haemoglobin in blood is vital for monitoring metabolic control in diabetics [1] [2] [3] . The development of many different methods of measurement (based on cation-exchange chromatography, electrophoresis, high performance liquid chromatography [HPLC] , affinity chromatography, radio and colorimetric immuno techniques) proves the importance of this assay [4] . Since the first HPLC method was described [5] a number of modifications have been reported (see the review by Ellis et al. [6] The reference method used for the evaluation was the Bio-Rad Laboratories microchromatographic method for HbAlc performed at 23 C, as previously described [7] .
The alkali denaturation method, modified according to Molden [8] analysis is: y 0"991 x -0"32; n 43; r 0"985, P < 0"001.
The dashed line correspond to the theoretical regression equation: y 1:000 x +0"00. Interference by abnormal haemoglobins was investigated by analysing haemolysates from subjects suffering from various haemoglobinopathies, which had previously been characterized. Figure 4 shows that in all the specimens analysed, the instrument produced an abnormal chromatogram; if an abnormal haemoglobin was present it showed as an anomalous peak, indicated as P4, P5 or P6.
In the case with HbS (see figure 4[b] together. The concentration of these fractions (13" 1%) is too high even for a sample from a diabetic person, and indicates the presence of interference. The concentration found using this analysis is significantly lower than that measured by CAE.
In the case of the Hb Lepore trait (see figure 4 [e]), a variant with electrophoretic mobility close to that ofHbF, an abnormal chromatographic pattern is shown, but detection of the type of the variant from the chromatogram is very uncertain.
Characterization is also impossible in the case of the sample showing the HbE trait (see figure 4[c] ). This mutant has a very low electrophoretic mobility at pH 8"4 (similar to that of HbA2) and elution is therefore expected The influence of so-called 'labile glycosylated haemoglobin' fractions on this method was also examined.
Erythrocytes were incubated separately with glucose (4"0 g/l) and with saline solution (9"0 g/1 NaC1) at 37 C, for up to 24 h. No significant increase in the HbAc levels of three blood samples (one from normal and two from diabetic subjects) after 24h of incubation with the glucose solution was detected (see figure 5[a] ). Similarly, no significant decrease in the initial HbAlc levels was found in two blood samples (one normal and one diabetic) incubated with saline for 24 h (see figure 5[b] ). In fact, the results ofthese determinations (see the dashed lines in figure 5 ) showed an increase in the HbA levels after the glucose incubations, and a significant decrease in the HbAc concentrations after the incubations with saline.
It can therefore be concluded that the method described here is insensitive to the presence of the 'labile fractions', which are reported to interfere strongly with many chromatographic methods.
In this evaluation no experiment was performed to test the effect of temperature on the analytical resolution of the minor haemoglobin fractions. Reports in the literature indicate that this effect is evident with all the procedures based on ion-exchange chromatography and, to a smaller extent, with those using affinity chromatography [12] . It is assumed that a thermoregulated column compartment within the apparatus will eliminate any interference from temperature variations on the chromatographic pattern.
In summary, it would appear that this system could be of significant value for the measurement of glycosylated haemoglobin. It combines good precision and accuracy with practicality for speed, technical skill requirements and safety. The system can also be useful in evaluating samples from subjects suffering from some haemoglobinopathies where diagnosis may frequently be missed by conventional chromatographic techniques, normally used to measure glycosylated haemoglobin levels.
